[1]
|
DeWane, M.E., Waldman, R. and Lu, J. (2020) Dermatomyositis: Clinical Features and Pathogenesis. American Acade-my of Dermatology, 82, 267-281. https://doi.org/10.1016/j.jaad.2019.06.1309
|
[2]
|
Bogdanov, I., Kazandjieva, J., Darlenski, R. and Tsankov, N. (2018) Dermatomyositis: Current Concepts. Clinics in Dermatology, 36, 450-458. https://doi.org/10.1016/j.clindermatol.2018.04.003
|
[3]
|
Chu, L.L. and Rohekar, G. (2019) Dermatomyositis. Ca-nadian Medical Association Journal, 191, E340.
https://doi.org/10.1503/cmaj.180947
|
[4]
|
Findlay, A.R., Goyal, N.A. and Mozaffar, T. (2015) An Overview of Polymyositis and Dermatomyositis. Muscle & Nerve, 51, 638-656. https://doi.org/10.1002/mus.24566
|
[5]
|
Maraví, T.Z., Burgos, P.I. and Prieto-González, S. (2020) Manifestaciones Clínicas y Anticuerpos Asociados y Específicos de Miositis en 15 Pacientes Chilenos con Dermatomiositis: Serie Clínica en un Centro Universitario [Clinical Manifestations and Antibody Profile in 15 Patients with Dermatomyositis]. Revista médica de Chile, 148, 160-167.
https://doi.org/10.4067/s0034-98872020000200160
|
[6]
|
Kume, A., Kashiwakuma, D., Kubodera, A., et al. (2021) Monoclonal B-Cell Lymphocytosis Exacerbated by Prednisolone Therapy for Dermatomyositis. Internal Medicine, 60, 2853-2858.
https://doi.org/10.2169/internalmedicine.6956-20
|
[7]
|
Leung, A.K.C., Lam, J.M., Alobaida, S., Leong, K.F. and Wong, A.H.C. (2021) Juvenile Dermatomyositis: Advances in Pathogenesis, Assessment, and Management. Current Pediatric Reviews, 17, 273-287.
https://doi.org/10.2174/1573396317666210426105045
|
[8]
|
Pinal-Fernandez, I. and Mammen, A.L. (2018) Der-matomyositis Etiopathogenesis: A Rebel Soldier in the Muscle. Current Opinion in Rheumatology, 30, 623-629. https://doi.org/10.1097/BOR.0000000000000540
|
[9]
|
Bolko, L., Gitiaux, C. and Allenbach, Y. (2019) Derma-tomyosites Nouveaux Anticorps, Nouvelle Classification. [Dermatomyositis: New Antibody, New Classification]. Med-ical Sciences (Paris), 35, 18-23.
https://doi.org/10.1051/medsci/2019178
|
[10]
|
Bodoki, L., Nagy-Vincze, M., Griger, Z. and Dankó, K. (2015) Der-matomyositisspezifische Antikörper [Dermatomyositis-Specific Antibodies]. Zeitschrift für Rheumatologie, 74, 363-369.
https://doi.org/10.1007/s00393-014-1524-7
|
[11]
|
Lauinger, J., Ghoreschi, K. and Volc, S. (2021) Characteristics of Dermatomyositis Patients with and without Associated Malignancy. Journal der Deutschen Dermatologischen Gesell-schaft, 19, 1601-1611.
https://doi.org/10.1111/ddg.14566
|
[12]
|
Udkoff, J. and Cohen, P.R. (2016) Amyopathic Dermatomyositis: A Con-cise Review of Clinical Manifestations and Associated Malignancies. American Journal of Clinical Dermatology, 17, 509-518.
https://doi.org/10.1007/s40257-016-0199-z
|
[13]
|
Orton, C., Topham, C. and Madigan, L.M. (2022) Paraneoplastic Dermatomyositis. The American Journal of Medicine, 135, 969-971. https://doi.org/10.1016/j.amjmed.2022.01.016
|
[14]
|
Schlecht, N., Sunderkötter, C., Niehaus, S. and Nashan, D. (2020) Update on Dermatomyositis in Adults. Journal der Deutschen Dermatologischen Gesellschaft, 18, 995-1013. https://doi.org/10.1111/ddg.14267
|
[15]
|
Gkegkes, I.D., Minis, E.E. and Iavazzo, C. (2018) Dermatomyositis and Colorectal Cancer: A Systematic Review. Irish Journal of Medical Science, 187, 615-620. https://doi.org/10.1007/s11845-017-1716-7
|
[16]
|
Tripathi, R. and Fernandez, A.P. (2021) Characteristics of Hos-pitalized Dermatomyositis Patients with Underlying Malignancy: A Nationally Representative Retrospective Cohort Study. Archives of Dermatological Research, 313, 473-482.
https://doi.org/10.1007/s00403-020-02127-5
|
[17]
|
Garg, T., Sanke, S., Chander, R., Agarwal, M., Agarwal, K. and Kumar, A. (2017) A Case of Dermatomyositis with Underlying Unusual Malignancy. Indian Journal of Dermatology, Venereology, and Leprology, 83, 473-476.
https://doi.org/10.1007/s00403-020-02127-5
|
[18]
|
Lau, L., Huang, L., Fu, E., Tan, T.C., Kong, K.O. and Lim, M.Y. (2021) Nasopharyngeal Carcinoma in Dermatomyositis. Clinical Otolaryngology, 46, 1082-1088. https://doi.org/10.1111/coa.13764
|